U.S., Jan. 7 -- An application to own the trademark for 'EYLONGIR' has been filed on Aug. 14, 2025.
Owner(s):
Regeneron Pharmaceuticals, Inc.; 777 Old Saw Mill River Road, , NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-06&serialNumber=99337615
Disclaimer: Curated by HT Syndication....